HK1202259A1 - Erythropoietin production-promoting agent - Google Patents
Erythropoietin production-promoting agentInfo
- Publication number
- HK1202259A1 HK1202259A1 HK15102801.8A HK15102801A HK1202259A1 HK 1202259 A1 HK1202259 A1 HK 1202259A1 HK 15102801 A HK15102801 A HK 15102801A HK 1202259 A1 HK1202259 A1 HK 1202259A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- promoting agent
- erythropoietin production
- erythropoietin
- production
- promoting
- Prior art date
Links
- 102000003951 Erythropoietin Human genes 0.000 title 1
- 108090000394 Erythropoietin Proteins 0.000 title 1
- 229940105423 erythropoietin Drugs 0.000 title 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
- C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011225382 | 2011-10-12 | ||
| JP2011225383 | 2011-10-12 | ||
| JP2012081581 | 2012-03-30 | ||
| PCT/JP2012/075947 WO2013054755A1 (ja) | 2011-10-12 | 2012-10-05 | エリスロポエチン産生促進剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1202259A1 true HK1202259A1 (en) | 2015-09-25 |
Family
ID=48081810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15102801.8A HK1202259A1 (en) | 2011-10-12 | 2015-03-18 | Erythropoietin production-promoting agent |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9469598B2 (xx) |
| EP (1) | EP2767279B1 (xx) |
| JP (1) | JP5818905B2 (xx) |
| CN (1) | CN104105482B (xx) |
| HK (1) | HK1202259A1 (xx) |
| TW (1) | TWI543960B (xx) |
| WO (1) | WO2013054755A1 (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9707196B2 (en) | 2011-10-12 | 2017-07-18 | Sbi Pharmaceuticals Co., Ltd. | Treatment agent and/or prophylactic agent for side effects of cancer drugs |
| JP5920902B2 (ja) * | 2012-07-23 | 2016-05-18 | 国立大学法人 東京大学 | 放射線障害の予防及び／又は治療剤 |
| JP6177343B2 (ja) * | 2013-10-29 | 2017-08-09 | 学校法人東京農業大学 | フラタキシン増強剤 |
| US11517540B2 (en) | 2015-01-09 | 2022-12-06 | The Board Of Trustees Of The University Of Illinois | Restoring physiology in iron-deficient organisms using small molecules |
| US10675242B2 (en) * | 2016-09-02 | 2020-06-09 | Sbi Pharmaceuticals, Co., Ltd. | Aqueous formulation containing 5-aminolevulinic acid or the like |
| JP2022166334A (ja) * | 2019-09-19 | 2022-11-02 | 国立大学法人 東京大学 | 鎌状赤血球症の改善及び／又は予防剤 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4754731B2 (ja) | 2001-07-31 | 2011-08-24 | コスモ石油株式会社 | 豚成育促進剤及び豚成育促進方法 |
| CA2521979A1 (en) | 2003-04-09 | 2004-10-28 | University Of Utah Research Foundation | Compositions and methods related to production of erythropoietin |
| US8614204B2 (en) * | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| JP4814501B2 (ja) * | 2004-09-02 | 2011-11-16 | コスモ石油株式会社 | 抗酸化機能向上剤 |
| CA2579032C (en) | 2004-09-02 | 2011-11-29 | Cosmo Oil Co., Ltd. | Use of an .delta.-amino acid as thymocyte growth agent |
| RU2376035C2 (ru) * | 2005-04-19 | 2009-12-20 | Хилл`С Пет Ньютришн, Инк. | Способы и композиции для предотвращения и лечения болезни почек у кошек |
| JP2006008720A (ja) | 2005-07-06 | 2006-01-12 | Yamaha Motor Co Ltd | 腎臓機能改善剤 |
| AU2006279429B2 (en) * | 2005-08-17 | 2010-02-25 | Hill's Pet Nutrition, Inc. | Methods and compositions for the prevention and treatment of kidney disease |
| JP5295652B2 (ja) | 2008-06-16 | 2013-09-18 | Ｓｂｉファーマ株式会社 | 光障害の軽減剤 |
| KR101322259B1 (ko) * | 2008-10-27 | 2013-10-28 | 에스비아이 파마 가부시키가이샤 | 5-아미노레불린산 혹은 그의 유도체, 또는 그들 염을 유효성분으로 하는 성인병의 예방·개선제 |
| JP5611548B2 (ja) | 2009-07-08 | 2014-10-22 | Ｓｂｉファーマ株式会社 | ５−アミノレブリン酸若しくはその誘導体、又はそれらの塩を有効成分とするがんの予防・改善剤 |
| US9018257B2 (en) * | 2011-03-24 | 2015-04-28 | Bar Ilan University | 5-aminolevulinic acid derivatives, methods for their preparation and uses thereof |
| EP2767276B1 (en) * | 2011-10-12 | 2018-10-03 | SBI Pharmaceuticals Co., Ltd. | Improving / prophylactic agent for chronic kidney disease |
-
2012
- 2012-10-05 CN CN201280060344.0A patent/CN104105482B/zh active Active
- 2012-10-05 JP JP2013538526A patent/JP5818905B2/ja active Active
- 2012-10-05 WO PCT/JP2012/075947 patent/WO2013054755A1/ja active Application Filing
- 2012-10-05 US US14/350,522 patent/US9469598B2/en active Active
- 2012-10-05 EP EP12839684.3A patent/EP2767279B1/en active Active
- 2012-10-11 TW TW101137457A patent/TWI543960B/zh active
-
2015
- 2015-03-18 HK HK15102801.8A patent/HK1202259A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TWI543960B (zh) | 2016-08-01 |
| JP5818905B2 (ja) | 2015-11-18 |
| CN104105482B (zh) | 2017-10-24 |
| EP2767279A4 (en) | 2015-05-06 |
| EP2767279A1 (en) | 2014-08-20 |
| JPWO2013054755A1 (ja) | 2015-03-30 |
| CN104105482A (zh) | 2014-10-15 |
| WO2013054755A1 (ja) | 2013-04-18 |
| US20140288172A1 (en) | 2014-09-25 |
| EP2767279B1 (en) | 2018-12-12 |
| US9469598B2 (en) | 2016-10-18 |
| TW201317206A (zh) | 2013-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3424953T3 (en) | Terapeutiske antistoffer | |
| GB201204966D0 (en) | Djml | |
| EP2715659A4 (en) | ABOUT FEED | |
| ZA201403090B (en) | Tropicalizing agent | |
| EP2754063A4 (en) | EXTENSIBILITY OF THE SMB2 PROTOCOL | |
| EP2723631A4 (en) | QUADFOILER | |
| HK1200314A1 (en) | R()-n-methyl-propargyl-aminoindan r()-n--- | |
| AP2014007621A0 (en) | 2-Thiopyrimidinones | |
| HK1200315A1 (en) | R()-n-formyl-propargyl-aminoindan r()-n--- | |
| GB201307749D0 (en) | Colonoscopy-preparation | |
| EP2695208A4 (en) | MICRO-THERMOCOUPLE | |
| HK1202259A1 (en) | Erythropoietin production-promoting agent | |
| SI2699681T1 (sl) | Hipoalergena snov | |
| EP2679138A4 (en) | Borescope | |
| EP2708561A4 (en) | BIO-PIN | |
| DK2770906T3 (en) | Applanationstonometer | |
| EP2684382A4 (en) | EARPHONES | |
| EP2787050A4 (en) | LECITHIN-Organogel formers | |
| TWI562734B (en) | Sense-improving agent | |
| EP2698098A4 (en) | campimeter | |
| EP2694655A4 (en) | pavec | |
| EP2764870A4 (en) | MEANS FOR IMPROVED SENSUAL ASSESSMENT | |
| EP2702929A4 (en) | campimeter | |
| AU4540P (en) | BUNNAN Baloskion tetraphyllum | |
| AU5171P (en) | Sunparamiho Mandevilla xamabilis |